Natera Inc. (NTRA) Financial Statements (2024 and earlier)

Company Profile

Business Address 13011 MCCALLEN PASS
AUSTIN, TX 78753
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments236,882898,306914,282737,274440,991153,868
Cash and cash equivalents  466,00584,38648,66861,92646,407
Short-term investments236,882432,301829,896688,606379,065107,461
Restricted cash and investments  86228187554,597
Receivables278,289244,385122,07478,56553,35162,223
Inventory, net of allowances, customer advances and progress billings40,75935,40626,90920,03112,39413,633
Inventory40,75935,40626,90920,03112,39413,633
Other undisclosed current assets702,61933,63429,64526,60616,3766,197
Total current assets:1,258,5491,211,8171,093,138862,663523,167240,518
Noncurrent Assets
Operating lease, right-of-use asset56,53771,87459,01321,39923,730
Property, plant and equipment111,21092,45365,51633,34823,28324,336
Other noncurrent assets15,40318,33018,82014,74312,4763,317
Total noncurrent assets:183,150182,657143,34969,49059,48927,653
TOTAL ASSETS:1,441,6991,394,4741,236,487932,153582,656268,171
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities60,85575,15868,14798,87473,73559,697
Employee-related liabilities44,01040,94130,37116,08812,668
Accounts payable14,99831,14827,2068,0968,60414,587
Accrued liabilities45,857  60,40749,04332,442
Deferred revenue16,61210,7777,40450,12556,016
Debt80,40280,35050,05250,05450,12350,153
Other liabilities149,405144,21493,353   
Other undisclosed current liabilities      4,131
Total current liabilities:307,274310,499218,956199,053179,874113,981
Noncurrent Liabilities
Long-term debt and lease obligation282,945281,653341,430223,73999,95373,357
Long-term debt, excluding current maturities282,945281,653280,394202,49373,65673,357
Liabilities, other than long-term debt86,15396,57822,79723,12524,1188,613
Accounts payable and accrued liabilities      8,613
Deferred revenue19,12820,00121,31822,80523,808
Other liabilities   1,479320310 
Operating lease, liability67,02576,57761,03621,24626,297
Other undisclosed noncurrent liabilities     40,058
Total noncurrent liabilities:369,098378,231364,227246,864124,071122,028
Total liabilities:676,372688,730583,183445,917303,945236,009
Equity
Equity, attributable to parent765,327705,744653,304486,236278,71132,162
Common stock111110987
Additional paid in capital3,145,8372,664,7302,050,4171,411,286976,955607,236
Accumulated other comprehensive income (loss)(3,085)(16,362)(2,287)4,259919(552)
Accumulated deficit(2,377,436)(1,942,635)(1,394,836)(929,318)(699,171)(574,529)
Total equity:765,327705,744653,304486,236278,71132,162
TOTAL LIABILITIES AND EQUITY:1,441,6991,394,4741,236,487932,153582,656268,171

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues1,082,571820,222625,486391,005302,328257,654
Cost of revenue(587,186)(412,586)(276,274)(202,266)(171,458)(163,764)
Cost of goods and services sold (2,175)(200)(900)(200)(321)(158,081)
Gross profit:495,385407,636349,212188,739130,87093,890
Operating expenses(941,630)(948,676)(817,386)(405,016)(247,157)(208,518)
Operating loss:(446,245)(541,040)(468,174)(216,277)(116,287)(114,628)
Interest and debt expense(12,638)(9,319)(8,305)(20,930)(10,693)(10,476)
Loss from continuing operations before equity method investments, income taxes:(458,883)(550,359)(476,479)(237,207)(126,980)(125,104)
Other undisclosed income (loss) from continuing operations before income taxes24,3533,5385,3817,5624,152(2,729)
Loss from continuing operations before income taxes:(434,530)(546,821)(471,098)(229,645)(122,828)(127,833)
Income tax expense(271)(978)(618)(98)(1,999)(321)
Loss from continuing operations:(434,801)(547,799)(471,716)(229,743)(124,827)(128,154)
Loss before gain (loss) on sale of properties:(471,716)(229,743)(124,827)(128,154)
Net loss available to common stockholders, diluted:(434,801)(547,799)(471,716)(229,743)(124,827)(128,154)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(434,801)(547,799)(471,716)(229,743)(124,827)(128,154)
Comprehensive loss:(434,801)(547,799)(471,716)(229,743)(124,827)(128,154)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent13,277(14,075)(6,546)3,3401,471214
Comprehensive loss, net of tax, attributable to parent:(421,524)(561,874)(478,262)(226,403)(123,356)(127,940)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: